About: Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Sector: Healthcare
Industry: Biotechnology
Latest price: $12.75 (+15.80%)
NVAX NASDAQ Novavax Inc
Novavax Inc share price
NVAX price activity
Last Price
$12.750
Change (24hr)
1.74 USD (15.80%)
Volume
18.89M
Volume (4w avg)
-
Open
$11.17
Day Range
$11.03 - $13.04
Previous Close
$11.01
Last Trade
09 Oct, 8:28 pm GMT+0
Delayed
09 Oct, 8:28 pm GMT+0
NVAX price performance
Delayed
09 Oct, 8:28 pm GMT+0
NVAX Market Signals